Exact Mass: 418.258

Exact Mass Matches: 418.258

Found 83 metabolites which its exact mass value is equals to given mass value 418.258, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CPA(18:1(11Z)/0:0)

(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (11Z)-octadec-11-enoate

C21H39O6P (418.2484)


cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(11Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.

   

CPA(18:1(9Z)/0:0)

(2-Hydroxy-2-oxo-1,3,2λ⁵-dioxaphospholan-4-yl)methyl (9Z)-octadec-9-enoic acid

C21H39O6P (418.2484)


cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:1(9Z)/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.

   

MFA

methyl (10R,13S,17S)-17-benzoyl-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3-carboxylate

C28H34O3 (418.2508)


Mfa is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Mfa can be found in french plantain, which makes mfa a potential biomarker for the consumption of this food product. MFA may refer to: .

   

Icariside C3

Icariside C3

C21H38O8 (418.2567)


   

Icariside C2

Icariside C2

C21H38O8 (418.2567)


   

Ophiopogonoside A

(2R,3R,4S,5S,6R)-2-[[(1R,2S,4aR,5R,8S,8aR)-5,8-dihydroxy-4a,8-dimethyl-2-propan-2-yl-1,2,3,4,5,6,7,8a-octahydronaphthalen-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


Ophiopogonoside A is a natural product found in Ophiopogon japonicus and Liriope muscari with data available.

   

Dendronobiloside B

Dendronobiloside B

C21H38O8 (418.2567)


   

Icariside C4

Icariside C4

C21H38O8 (418.2567)


   

Pterodontoside E

Pterodontoside E

C21H38O8 (418.2567)


   

Pterodontoside F

Pterodontoside F

C21H38O8 (418.2567)


   

(1R,4R,5R,7R,10S)-10,11,15-trihydroxyguaiane 11-O-beta-D-glucopyranoside

(1R,4R,5R,7R,10S)-10,11,15-trihydroxyguaiane 11-O-beta-D-glucopyranoside

C21H38O8 (418.2567)


   

(2E,4E,6E)-cyclo-[(NMe-L-Ala)-L-Val-(Nalpha-octa-2,4,6-trienoyl-L-Orn)]|sclerotiotide A

(2E,4E,6E)-cyclo-[(NMe-L-Ala)-L-Val-(Nalpha-octa-2,4,6-trienoyl-L-Orn)]|sclerotiotide A

C22H34N4O4 (418.258)


   

celerioside E|eudesmane-1beta,4alpha,11-triol 11-O-beta-D-glucopyranoside

celerioside E|eudesmane-1beta,4alpha,11-triol 11-O-beta-D-glucopyranoside

C21H38O8 (418.2567)


   

eudesman-3,4alpha,11-triol-11-O-beta-D-glucopyranoside

eudesman-3,4alpha,11-triol-11-O-beta-D-glucopyranoside

C21H38O8 (418.2567)


   
   

(2E,6E)-10-beta-D-glucopyranosyl-1,10,11-trihydroxy-3,7,11-trimethyldodeca-2,6-diene

(2E,6E)-10-beta-D-glucopyranosyl-1,10,11-trihydroxy-3,7,11-trimethyldodeca-2,6-diene

C21H38O8 (418.2567)


   
   

C22H34N4O4_N-Methyl-N-[(2E,4E,6E)-2,4,6-octatrienoyl]valylalanylprolinamide

NCGC00385036-01_C22H34N4O4_N-Methyl-N-[(2E,4E,6E)-2,4,6-octatrienoyl]valylalanylprolinamide

C22H34N4O4 (418.258)


   

Gly Lys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-3-hydroxypropanoic acid

C17H34N6O6 (418.254)


   

Gly Lys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]hexanoic acid

C17H34N6O6 (418.254)


   

Gly Ser Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]hexanoic acid

C17H34N6O6 (418.254)


   

Lys Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C17H34N6O6 (418.254)


   

Lys Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C17H34N6O6 (418.254)


   

Lys Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C17H34N6O6 (418.254)


   

Lys Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C17H34N6O6 (418.254)


   

Lys Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C17H34N6O6 (418.254)


   

Lys Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C17H34N6O6 (418.254)


   

Ser Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]hexanoic acid

C17H34N6O6 (418.254)


   

Ser Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}hexanoic acid

C17H34N6O6 (418.254)


   

Ser Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]hexanamido]acetic acid

C17H34N6O6 (418.254)


   

CPA(18:1)

1-(11Z-Octadecenoyl)-cyclophosphatidic acid

C21H39O6P (418.2484)


   

cLPA(18:1)

1-(9Z-octadecenoyl)-sn-glycero-2,3-cyclic phosphate

C21H39O6P (418.2484)


   

1-linoleyl glycerone-3-phosphate

1-(9Z,12Z-octadecadienyl)-glycerone 3-phosphate

C21H39O6P (418.2484)


   

CPA 18:1

1-(9Z-octadecenoyl)-sn-glycero-2,3-cyclic phosphate

C21H39O6P (418.2484)


   

Erythronolide A

Erythronolide A

C21H38O8 (418.2567)


   

1-(9Z,12Z)-octadecadienylglycerone 3-phosphate

1-(9Z,12Z)-octadecadienylglycerone 3-phosphate

C21H39O6P (418.2484)


A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as (9Z,12Z)-octadecadienyl.

   

1-Oleylglycerone 3-phosphate(2-)

1-Oleylglycerone 3-phosphate(2-)

C21H39O6P-2 (418.2484)


   

(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (9Z)-octadec-9-enoate

(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (9Z)-octadec-9-enoate

C21H39O6P (418.2484)


   

(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (11Z)-octadec-11-enoate

(2-hydroxy-2-oxo-1,3,2$l^{5}-dioxaphospholan-4-yl)methyl (11Z)-octadec-11-enoate

C21H39O6P (418.2484)


   

1-oleoyl-sn-glycerol 2,3-cyclic phosphate

1-oleoyl-sn-glycerol 2,3-cyclic phosphate

C21H39O6P (418.2484)


A 1-acyl-sn-glycerol 2,3-cyclic phosphate having oleoyl as the 1-O-acyl group.

   

1-Oleylglycerone 3-phosphate(2-)

1-Oleylglycerone 3-phosphate(2-)

C21H39O6P (418.2484)


A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleylglycerone 3-phosphate; major species at pH 7.3.

   

2-[(5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

n-(2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl)octa-2,4,6-trienimidic acid

n-(2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl)octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

2-{[1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2e,4e,6z)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid

(2e,4e,6z)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10e)-2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10e)-2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

2-[(2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(2,12-dihydroxy-2,6,10-trimethyldodeca-6,10-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2r,3r,4r,5r)-4-{[(3r,4ar,5s,8as)-3-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}hexane-1,2,3,5,6-pentol

(2r,3r,4r,5r)-4-{[(3r,4ar,5s,8as)-3-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methoxy}hexane-1,2,3,5,6-pentol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,7s,8as)-4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,7s,8as)-4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(3r,4s,5r,6s,7s,11r,12s,13r,14r)-14-ethyl-4,6,9,12-tetrahydroxy-9-(hydroxymethyl)-3,5,7,11,13-pentamethyl-1-oxacyclotetradecane-2,10-dione

(3r,4s,5r,6s,7s,11r,12s,13r,14r)-14-ethyl-4,6,9,12-tetrahydroxy-9-(hydroxymethyl)-3,5,7,11,13-pentamethyl-1-oxacyclotetradecane-2,10-dione

C21H38O8 (418.2567)


   

(2e,4e,6e)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid

(2e,4e,6e)-n-[(3s,6s,9s)-2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl]octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

(2r,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,6e,10s)-10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2r,3s,4s,5s,6s)-2-{[(1r,2s,4ar,5r,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-{[(1r,2s,4ar,5r,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(4as,6as,12br,14as,14bs)-10-hydroxy-6a,9,12b,14a-tetramethyl-2-methylidene-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-4a-carbaldehyde

(4as,6as,12br,14as,14bs)-10-hydroxy-6a,9,12b,14a-tetramethyl-2-methylidene-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-4a-carbaldehyde

C28H34O3 (418.2508)


   

2-[(3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

2-[(2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4as,5s,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4as,5s,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-({2-[(2r,4ar,5s,8r,8ar)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-({2-[(2r,4ar,5s,8r,8ar)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

2-{[4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

11-dodecyl-11h-5,10-dioxatetraphen-12-one

11-dodecyl-11h-5,10-dioxatetraphen-12-one

C28H34O3 (418.2508)


   

(2e,4e)-n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid

(2e,4e)-n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione

3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione

C28H34O3 (418.2508)


   

(2r,3r,4s,5s,6r)-2-{[(1s,4s,4as,6s,8as)-4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,4s,4as,6s,8as)-4-hydroxy-6-(2-hydroxypropan-2-yl)-4,8a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

2-[(10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(10,11-dihydroxy-3,7,11-trimethyldodeca-1,6-dien-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(6e)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(6e)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6s)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6s)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(8as,11r,12ar,12bs,14as)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione

(8as,11r,12ar,12bs,14as)-3-hydroxy-4,7,8a,11,12b,14a-hexamethyl-9,11,12,12a,13,14-hexahydro-8h-picene-2,10-dione

C28H34O3 (418.2508)


   

13-isopropyl-15-[3-methoxy-5-(1h-pyrrol-2-yl)furan-2-yl]-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(15),2,14(16)-triene

13-isopropyl-15-[3-methoxy-5-(1h-pyrrol-2-yl)furan-2-yl]-2-azatricyclo[10.2.1.1³,¹⁴]hexadeca-1(15),2,14(16)-triene

C27H34N2O2 (418.262)


   

(2s,3s,4s,5s,6s)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4s,5s,6s)-2-{[(3s,6e,10s)-3,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3r,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4s,5s,6s)-2-{[(3s,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6s)-2-{[(3s,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2s,3r,4r,5r,6s)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-{[(1r,3ar,4r,5r,7as)-1-hydroxy-1-(hydroxymethyl)-5-isopropyl-7a-methyl-hexahydro-2h-inden-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2e,4e,6e)-n-[(3s,6s,9s)-2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl]octa-2,4,6-trienimidic acid

(2e,4e,6e)-n-[(3s,6s,9s)-2,8-dihydroxy-6-isopropyl-3,4-dimethyl-5-oxo-1,4,7-triazacyclododeca-1,7-dien-9-yl]octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

2-{[4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid

n-(2,5-dihydroxy-6-isopropyl-3,7-dimethyl-8-oxo-1,4,7-triazacyclododeca-1,4-dien-9-yl)octa-2,4,6-trienimidic acid

C22H34N4O4 (418.258)


   

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,6e,10s)-2,10-dihydroxy-2,6,10-trimethyldodeca-6,11-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)


   

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4ar,5r,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,2s,4ar,5r,8s,8ar)-5,8-dihydroxy-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C21H38O8 (418.2567)